Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Teva Pharmaceutical Industries Ltd. - Investors
 "Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook")
Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance | Business Wire
Teva shares climb as third-quarter sales top estimates - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals Interviews | Comparably
Teva Reports Second Quarter 2023 Financial Results
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Profit Falls on Write-Downs - WSJ
Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease - Huntington's Disease News
Teva Pharmaceuticals Culture | Comparably
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva | Statista
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharamceutical (NYSE:TEVA) Surges After Earnings Report - TipRanks.com
